Routine Test Management
The first automated solution customized to individual plan requirements, ensuring effortless compliance with routine lab policies.
Driving Lab Excellence for BCBS Plans: Proven Strategies for Cost Savings & Clinical Impact
Are rising lab testing costs straining your health plan’s resources? Avalon helps Blue Cross Blue Shield Plans optimize lab testing, reduce costs, and improve patient outcomes.
Join us on April 1, 2025, from 2 – 3 EST for this exclusive webinar where you’ll learn:
✔ Maximizing Lab Benefit Management (LBM) & Routine Test Management (RTM): Optimizing testing through evidence-based strategies to cut costs and improve compliance
✔ Proven Success with BCBS Plans: Cost savings and improved lab utilization from partnerships with 19 BCBS plans
✔ FEP Pilot Case Study: Insights on savings and efficiency from Avalon’s work with the FEP Director’s Office
✔ The Future of Lab Testing: Promoting science-driven value-based care and advanced diagnostics
Expert speakers will highlight real-world success stories, including our collaboration with the Blue Cross Blue Shield Association’s Federal Employee Program (FEP):
• Nicole Smith, MS, BSN, RN, CCM - Director of Pilot Innovations, Federal Employee Program, Blue Cross Blue Shield Association
• Daria Odom - Program Manager, Pilot Innovations, Blue Cross Blue Shield Association
• Sara Sabin – SVP Business Development, Avalon Healthcare Solutions
Don’t Miss Out – Register Now
Register even if you can’t attend live, and we’ll send you the recording after the session.
Learn why we're trusted by 19 Blues Plans
Our Blues Plans partnerships grew by 27% in 2024
Industry Challenge:
Consider how essential lab testing is to healthcare.
Around 14 billion clinical lab tests are performed annually in the U.S., making them the most utilized medical benefit. Lab results are involved in roughly 70% of clinical decisions. Despite their importance, around 30% of lab tests conducted in the U.S. may be unnecessary, while another 30% of patients still need the testing they genuinely need.
And lab testing is expensive. In 2021, Medicare alone spent $9.3 billion on tests, a record 17% increase from the previous year.
Our Solution:
Our flagship solution, Avalon's Routine Test Management (RTM) program, streamlines the process of determining coverage criteria to eliminate unnecessary utilization of high-volume, low-cost laboratory tests while ensuring that physicians and patients are unaffected.
10 – 20% savings on outpatient routine lab spend in 2023
Learn More
Avalon to Team with Sentara Health Plans to Offer Genetic Test Management
What to Expect in Healthcare in 2025
First Report Managed Care: How to Maximize the Value of GLP-1 Drugs While Improving Health Equity
Avalon November Webinar: Breaking Down Barriers and Optimizing Drug Treatment for Cancer Patients
Urban Health Today: Drs. Julie Schulz and Michael Dovidio on using Lab Values for GLP-1 Coverage
2024 Lab Trend Report: Key Points and Highlights
Contact Us
Avalon Healthcare Solutions